Valuation : Olympus Corporation

Market Cap 2,217B 13.97B 12.05B 11.35B 10.34B 19.34B 1,320B 19.48B 134B 52.17B 675B 52.46B 51.31B P/E 2027 *
21.3x
P/E 2028 * 18.3x
Enterprise Value 2,298B 14.49B 12.5B 11.77B 10.73B 20.05B 1,368B 20.2B 139B 54.09B 700B 54.4B 53.21B EV / Sales 2027 *
2.13x
EV / Sales 2028 * 2.04x
Free-Float
94.58%
Yield 2027 *
1.48%
Yield 2028 * 1.55%
1 day-0.90%
1 week-1.43%
Current month-0.30%
1 month+15.47%
3 months+16.28%
6 months+42.98%
Current year+3.71%
1 week 13.08
Extreme 13.08
13.6
1 month 11.36
Extreme 11.355
13.72
Current year 8.08
Extreme 8.08
13.72
1 year 8.08
Extreme 8.08
13.73
3 years 8.08
Extreme 8.08
19.69
5 years 8.08
Extreme 8.08
74.99
10 years 6.26
Extreme 6.2625
74.99
Manager TitleAgeSince
Chief Executive Officer 63 31/05/2025
Director of Finance/CFO 59 31/03/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 31/03/2023
Director/Board Member 41 31/05/2019
Director/Board Member 63 31/05/2019
Change 5-day change 1-year change 3-year change Capi.($)
-0.90%-1.43% - - 13.97B
+1.34%-3.97%+24.82%+9.21% 225B
+1.44%-2.53%+3.00%-20.96% 148B
+0.71%+0.39%-20.72%+19.80% 131B
+0.60%+0.42%-54.65%-9.79% 70.1B
+0.09%+0.04%+11.07%+18.91% 52.35B
+0.41%+0.51%-14.70%-13.84% 50.91B
+0.97%-2.38%+20.91%+24.18% 42.68B
+1.57%-0.48%+39.03%+46.68% 40.5B
-0.21%-2.05%-14.80%+45.03% 33.3B
Average +0.55%-1.55%-0.67%+13.25% 88.2B
Weighted average by Cap. +0.91%-2.12%+1.62%+7.06%

Financials

2027 *2028 *
Net sales 1,079B 6.8B 5.87B 5.53B 5.04B 9.41B 643B 9.49B 65.45B 25.4B 329B 25.54B 24.99B 1,117B 7.04B 6.07B 5.72B 5.21B 9.74B 665B 9.82B 67.73B 26.29B 340B 26.44B 25.86B
Net income 105B 662M 571M 538M 490M 916M 62.49B 922M 6.37B 2.47B 31.95B 2.48B 2.43B 122B 767M 662M 623M 568M 1.06B 72.45B 1.07B 7.38B 2.86B 37.04B 2.88B 2.82B
Net Debt 81.71B 515M 444M 419M 381M 713M 48.65B 718M 4.96B 1.92B 24.87B 1.93B 1.89B 64.09B 404M 348M 328M 299M 559M 38.16B 563M 3.89B 1.51B 19.51B 1.52B 1.48B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
02/09/26 US$13.14 -0.90% 236,447
01/09/26 US$13.26 +0.61% 380,865
31/08/26 US$13.18 -1.13% 20,564
28/08/26 US$13.33 -0.52% 12,782
27/08/26 US$13.40 +0.53% 47,064
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,085.50JPY
Average target price
2,157.69JPY
Spread / Average Target
+3.46%

Quarterly revenue - Rate of surprise